The global Urokinase market is valued at 34938.95 K USD in 2018 is expected to reach 52911.17 K USD by the end of 2025, growing at a CAGR of 6.14% during 2020-2025.

This report focuses on Urokinase volume and value at global level, regional level and company level. From a global perspective, this report represents overall Urokinase market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: USA, Europe, China.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
NDPHARM
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
Techpool
Microbic Biosystems Inc
LIVZON

Segment by Regions
USA
Europe
China
Rest of World

Segment by Type
Urokinase Powder
Urokinase Solution

Segment by Application
Hospital
Clinic
Others